These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18978306

  • 21. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY, Lin CT, Kuo SY, Chang DK, Wu HC.
    Cancer Res; 2007 Nov 15; 67(22):10958-65. PubMed ID: 18006841
    [Abstract] [Full Text] [Related]

  • 22. Identification of nose-to-brain homing peptide through phage display.
    Wan XM, Chen YP, Xu WR, Yang WJ, Wen LP.
    Peptides; 2009 Feb 15; 30(2):343-50. PubMed ID: 19007831
    [Abstract] [Full Text] [Related]

  • 23. Organ targeting in vivo using phage display peptide libraries.
    Pasqualini R, Ruoslahti E.
    Nature; 1996 Mar 28; 380(6572):364-6. PubMed ID: 8598934
    [Abstract] [Full Text] [Related]

  • 24. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques.
    Burtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN.
    Mol Pharm; 2009 Mar 28; 6(6):1903-19. PubMed ID: 19743879
    [Abstract] [Full Text] [Related]

  • 25. Molecular addresses of tumors: selection by in vivo phage display.
    Li XB, Schluesener HJ, Xu SQ.
    Arch Immunol Ther Exp (Warsz); 2006 Mar 28; 54(3):177-81. PubMed ID: 16736105
    [Abstract] [Full Text] [Related]

  • 26. Dendrimer display of tumor-homing peptides.
    Lempens EH, Merkx M, Tirrell M, Meijer EW.
    Bioconjug Chem; 2011 Mar 16; 22(3):397-405. PubMed ID: 21261269
    [Abstract] [Full Text] [Related]

  • 27. Designing scaffolds of peptides for phage display libraries.
    Uchiyama F, Tanaka Y, Minari Y, Tokui N.
    J Biosci Bioeng; 2005 May 16; 99(5):448-56. PubMed ID: 16233816
    [Abstract] [Full Text] [Related]

  • 28. Sequential determination of ligands binding to discrete components in heterogeneous mixtures by iterative panning and blocking (IPAB).
    Messmer BT, Benham CJ, Thaler DS.
    J Mol Biol; 2000 Feb 25; 296(3):821-32. PubMed ID: 10677284
    [Abstract] [Full Text] [Related]

  • 29. Generation and selection of immunized Fab phage display library against human B cell lymphoma.
    Shen Y, Yang X, Dong N, Xie X, Bai X, Shi Y.
    Cell Res; 2007 Jul 25; 17(7):650-60. PubMed ID: 17621306
    [Abstract] [Full Text] [Related]

  • 30. Application of phage display to discovery of tumor-specific homing peptides: developing strategies for therapy and molecular imaging of cancer.
    Seung-Min L, Gil-Suk Y, Eun-Sang Y, Tae-Gyun K, In-San K, Byung-Heon L.
    Methods Mol Biol; 2009 Jul 25; 512():355-63. PubMed ID: 19347288
    [Abstract] [Full Text] [Related]

  • 31. [A Paralytic shellfish poisoning GTX2,3 mimic peptide isolated from phage display: characterization and potential applications].
    Xiang Z, Liu BY, Hou XR, Xiang JJ, Fu N.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun 25; 26(6):530-2. PubMed ID: 20487642
    [Abstract] [Full Text] [Related]

  • 32. Identification of peptide sequences that target to the brain using in vivo phage display.
    Li J, Zhang Q, Pang Z, Wang Y, Liu Q, Guo L, Jiang X.
    Amino Acids; 2012 Jun 25; 42(6):2373-81. PubMed ID: 21792566
    [Abstract] [Full Text] [Related]

  • 33. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
    Winthrop MD, DeNardo SJ, Albrecht H, Mirick GR, Kroger LA, Lamborn KR, Venclovas C, Colvin ME, Burke PA, DeNardo GL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
    [Abstract] [Full Text] [Related]

  • 34. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells.
    Spear MA, Breakefield XO, Beltzer J, Schuback D, Weissleder R, Pardo FS, Ladner R.
    Cancer Gene Ther; 2001 Jul 01; 8(7):506-11. PubMed ID: 11498772
    [Abstract] [Full Text] [Related]

  • 35. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules.
    Eisenhardt SU, Schwarz M, Bassler N, Peter K.
    Nat Protoc; 2007 Jul 01; 2(12):3063-73. PubMed ID: 18079705
    [Abstract] [Full Text] [Related]

  • 36. [Establishment of biopanning model of phage display peptide library in the blood vessels of excised human osteosarcoma vasculature and its significance].
    Li ZQ, Shi ZJ, Hao WB, L H.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar 01; 22(3):212-4. PubMed ID: 12390765
    [Abstract] [Full Text] [Related]

  • 37. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
    Zhao H, Hermsen T, Stet RJ, Skjødt K, Savelkoul HF.
    Mol Immunol; 2008 Mar 01; 45(6):1658-64. PubMed ID: 18206244
    [Abstract] [Full Text] [Related]

  • 38. Quantitative PCR-based approach for rapid phage display analysis: a foundation for high throughput vascular proteomic profiling.
    Ballard VL, Holm JM, Edelberg JM.
    Physiol Genomics; 2006 Aug 16; 26(3):202-8. PubMed ID: 16705020
    [Abstract] [Full Text] [Related]

  • 39. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.
    Balestrieri ML, Napoli C.
    Eur J Cancer; 2007 May 16; 43(8):1242-50. PubMed ID: 17449238
    [Abstract] [Full Text] [Related]

  • 40. Vascular targeting with phage peptide libraries.
    Pasqualini R.
    Q J Nucl Med; 1999 Jun 16; 43(2):159-62. PubMed ID: 10429511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.